Medtronic (MDT): FY26 Q2 earnings call, Nov 18, 2025
No Kalshi or Polymarket word markets were listed for Medtronic’s Nov 18, 2025 earnings call (FY26 Q2). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
18 matches for “Tariff”; 5 quoted, at least 25 words apart.
…as we scale our Cast business and separate the diabetes business. Next, tariffs were a 20 basis points headwind, and finally, FX was about a…
…we expect our fiscal 2026 gross margin to be slightly up ex tariffs, with pricing, FX, and COGS efficiency programs more than offsetting the negative…
…fiscal 2026 adjusted operating profit to grow approximately 5% or 7% excluding tariffs. Our fiscal 2026 operating margin is expected to be roughly flat ex…
…points in Q3 as the quarter includes half the annual impact of tariffs. In addition, the expected growth acceleration in CAS and diabetes will continue…
…SG&A together, so we'll start seeing a lift there. And so ex tariffs, we'll have gross margin and operating margin leverage in the second half.…
Agents: this page as TSV at /api/v1/appearances/medtronic:2025-11-18:earnings_call · words: /api/v1/brief?appearance=medtronic:2025-11-18:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP